Research / STE / Fundamental state Inspectable configuration
State dimensions Filing 0001757898-22-000019 General Corporate
Debt relative to revenue 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
246.13% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.02% · OPTIONAL · VALID
Operating cash generation 54th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.04% · OPTIONAL · VALID
Revenue growth 56th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
19.42% · CORE · VALID
Inventory pressure 92th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
53.65% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
44.77% · CORE · VALID
Operating margin 23th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
13.70% · CORE · VALID
R&D intensity 62th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.14% · OPTIONAL · VALID
SBC intensity 15th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.78% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 64.24%
Current 246.13%
Delta 181.89% Capex Intensity Increased
Previous 6.27%
Current 10.02%
Delta 3.75% Cash Generation Increased
Previous 14.94%
Current 20.04%
Delta 5.10% Growth Decreased
Previous 47.55%
Current 19.42%
Delta -28.13% Inventory Pressure Increased
Previous 12.54%
Current 53.65%
Delta 41.10% Margin Increased
Previous 43.98%
Current 44.77%
Delta 0.80% Profitability Increased
Previous 9.28%
Current 13.70%
Delta 4.41% R And D Intensity Increased
Previous 1.92%
Current 2.14%
Delta 0.22% Sbc Intensity Decreased
Previous 1.26%
Current 0.78%
Delta -0.48% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.